with nasopharyngeal carcinoma (NPC) and can be detected in early premalignant lesions of nasopharyngeal epithelium. The latent membrane protein 1 (LMP1) is an oncoprotein encoded by the EBV and is believed to play a role in transforming premalignant nasopharyngeal epithelial cells into cancer cells. RASSF1A is a tumorsuppressor gene commonly inactivated in many types of human cancer including NPC. In this study, we report a novel function of LMP1, in down-regulating RASSF1A expression in human epithelial cells. Downregulation of RASSF1A expression by LMP1 is dependent on the activation of intracellular signaling of NF-jB involving the C-terminal activating regions (CTARs) of LMP1. LMP1 expression also suppresses the transcriptional activity of the RASSF1A core promoter. RASSF1A stabilizes microtubules and regulates mitotic events. Aberrant mitotic spindles and chromosome aberrations are reported phenotypes in RASSF1A inactivated cells. In this study, we observed that LMP1 expression in human epithelial cells could induce aberrant mitotic spindles, disorganized interphase microtubules and aneuploidy. LMP1 expression could also suppress microtubule dynamics as exemplified by tracking movements of the growing tips of microtubules in live cells by transfecting EGFP-tagged EB1 into cells. The aberrant mitotic spindles and interphase microtubule organization induced by LMP1 could be rescued by transfecting RASSF1A expression plasmid into cells. Downregulation of RASS-F1A expression by LMP1 may facilitate its role in transformation of premalignant nasopharyngeal epithelial cells into cancer cells.
Introduction
Nasopharyngeal carcinoma (NPC) is a common cancer in Southern China. The incidence rate among ethnic Cantonese living in this region is approximately 30-fold higher compared to incidence rate worldwide. The histopathological type of NPC in Southern China is mainly of the undifferentiated type, and is closely associated with Epstein-Barr virus (EBV) infection. Ethnical clustering of NPC strongly suggests the interplay of genetic susceptibility and environmental factors in its development (Lo and Huang, 2002) . Genetic predisposition to NPC among Southern Chinese may confer cellular susceptibility to transformation actions of EBV encoded oncogenes.
Latent infection of EBV in premalignant nasopharyngeal lesions was shown to be an early event in the development of NPC (Pathmanathan et al., 1995; Lo et al., 2004b) . The EBV encoded latent membrane protein 1 (LMP1) has been shown to be capable of transforming in vitro rodent fibroblasts into tumorigenic cells (Wang et al., 1985) . Two domains in the cytoplasmic carboxyl tail of LMP1 (CTAR1 and CTAR2), are essential for activation of multiple cellular signaling pathways, notably the NF-kB pathway (Eliopoulos and Young, 2001; Tsao et al., 2002a) , which mediates many downstream pathogenic properties of LMP1.
The p53 and Rb tumor-suppressor genes are crucial in cell cycle regulation checkpoints and are common targets of inactivation by viral oncogenes, including large T antigen of SV40 virus (De Luca et al., 1997) and E6 and E7 of human papilloma virus (Balsitis et al., 2005) . However, functional interactions of EBV oncogenes with tumor-suppressor genes during NPC development are unclear. We have previously identified multiple potential loci of NPC, for tumor-suppressor genes using highresolution allelotyping and array comparative genomic hybridization. The highest frequencies of allelic losses were identified in chromosomes 3p (96.3%) and 9p (85.2%) (Lo et al., 2004b) . RASSF1A is a potential tumor-suppressor gene residing on chromosome 3p21, which is commonly inactivated in NPC by allelic deletion and promoter methylation (Chow et al., 2004 (Chow et al., , 2006 . Allelic loss of RASSF1A locus could be detected in microdissected tissues from low-and high-grade dysplastic nasopharyngeal epithelial lesions (Lo and Huang, 2002; Chow et al., 2004) . RASSF1A is also commonly inactivated in other human cancers including gastric cancer (Kang et al., 2002) , hepatocellular carcinoma (Yu et al., 2002) and small-cell lung cancer (Dammann et al., 2001) ; suggesting its common involvement in human carcinogenesis. Reconstitution of RASSF1A expression in a NPC cell line, C666-1, induced loss of viability, growth suppression, diminished invasiveness and anchorage-independence growth properties (Chow et al., 2004) . A lower expression level of RASSF1A was detected in an immortalized nasopharyngeal epithelial cell line expressing LMP1 (Tsao et al., 2002b) , which prompted us to investigate if LMP1 may regulate RASSF1A expression in cells.
An important function of RASSF1A is regulation of microtubule functions . RASSF1A colocalizes with cytoplasmic microtubules in interphase cells. As cells enter prophase during mitosis, RASSF1A is relocated to the centrosomes, then to the mitotic spindles at metaphase and spindle poles at anaphase. At cytokinesis, the protein is relocated to the mid-body (Song et al., 2004) . RASSF1A also stabilizes microtubules (Rong et al., 2004) , its expression protects cells from the action of tubulin depolymerizing drug such as nocodazole (Vos et al., 2004) . Mouse embryonic fibroblasts generated from RASSF1A null mice showed increased sensitivity to nocodazole . Inactivation of RASSF1A is associated with abnormal mitotic spindle formation and chromosome instability (Song et al., 2004; Vos et al., 2004) In this study, we showed that LMP1 could downregulate RASSF1A expression, in multiple epithelial cell types. We have also examined the involvement of potential cellular signaling pathways in the suppression of RASSF1A. Our study reveals that downregulation of RASSF1A expression by LMP1 induces abnormal microtubule function, resulting in aberrant mitotic spindles and chromosome instability, hence facilitate tumorigenesis.
Results

LMP1 downregulates RASSF1A expression
The effect of LMP1 on RASSF1A expression was first observed in an immortalized nasopharyngeal epithelial cell line (NP69), which has been previously shown to be highly sensitive to the transformation action of LMP1 (Tsao et al., 2002b) . Western blotting analysis showed that RASSF1A expression was downregulated in NP69 cells stably expressing LMP1 when compared with the parental cell line (NP69) (Figure 1a ). To confirm that downregulation of RASSF1A expression in NP69LMP1 is not a result of selective growth of NP69LMP1 clones with low RASSF1A expression, we next examined the effectiveness of LMP1 to suppress RASSF1A expression by transient transfection of LMP1 expression plasmid. As the transfection efficiency of the immortalized NP69 cells is low, HeLa, HaCaT and SCC1F cells were chosen as recipient cells because of their higher rates of transient transfection (50-80%). The prevalent 2117-LMP1 variant isolated from NPC patients in Hong Kong (Cheung et al., 1998) was used in this part of the study. The functional properties of this LMP1 variant have been previously characterized (Lo et al., 2003 (Lo et al., , 2004a . Downregulation of RASSF1A could be readily demonstrated in all the epithelial cell types transiently transfected with the LMP1 expression plasmid (Figure 1b) . Furthermore, downregulation of RASSF1A by transient transfection of LMP1 was shown to be dose-dependent in HeLa cells, confirming that LMP1 is directly involved in the downregulation of RASSF1A expression ( Figure 1c ). The concentrations of LMP1 plasmids used for transfection were 0.3-1.2 mg/10 6 cells, which is within the normal range of LMP1 concentrations used in cell signaling studies (Eliopoulos et al., 1999b; Li et al., 2004) . Suppression of RASSF1A expression in LMP1 expressing cells could also be demonstrated at the transcription level by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) (Figure 1d ). Consistent with our previous observations (Chow et al., 2004) , RASSF1A mRNA was undetectable in an EBV positive cell line, C666-1; but high in HK1, an EBV-negative NPC cell line established from a well-differentiated squamous carcinoma of NPC specimen. RASSF1A mRNA could be detected in NP69, SCC12F and HaCaT cells. The RASSF1A mRNA level is highly reduced in NP69 cells stably expressing LMP1; and in SCC12F and HaCaT cells after transient expression of LMP1. Hence, downregulation of RASS-F1A expression by LMP1 could be demonstrated at both transcription and protein expression levels. Downregulation of RASSF1A expression by LMP1 involves NF-kB activation As aforementioned, LMP1 could activate multiple cell signaling pathways in cells including MAPK, JNK, PI3K and NF-kB. To explore the potential involvement of these signaling pathways in mediating LMP1-induced downregulation of RASSF1A, the effects of specific inhibitors on RASSF1A expression were examined. The concentrations and treatment times of these inhibitors for these signaling pathways have been optimized in previous studies (Li et al., 2004; Wu et al., 2006) . The effectiveness of each inhibitor in suppressing the kinase activities of MAPK, JNK and PI3K was confirmed by examining the phosphorylation status of their respective downstream targets (Figure 2A, a-c) . Inhibition of NF-kB activation was achieved by co-transfecting LMP1 with a genetic inhibitor of NF-kB (pUSE-IkBa S32/ S36). The IkBa S32/S36 mutant has two mutated phosphorylation sites (S32 and S36), which resists phosphorylation degradation and prevents activation of NF-kB in LMP1 expressing cells. The effective inhibition of NF-kB was confirmed by examining the phosphorylation status of IkB ( Figure 2B, a) . Inhibition of MAPK, JNK and PI3K pathways was not effective in restoring LMP1-induced downregulation of RASSF1A expression (Figure 2A, a-c) . In contrary, co-transfection of LMP1 with the NF-kB inhibitor (IkBa S32/S36) effectively abolished the LMP1-induced downregulation of RASSF1A in HeLa and HaCaT cells ( Figure 2B, a) . In addition, activating NF-kB signaling by overexpressing the IkB kinase alpha subunit (IKKa) led to downregulation of RASSF1A expression, confirming the involvement of NF-kB signaling pathway ( Figure 2B, b) .
The C-terminal activation regions of LMP1 are required to downregulate RASSF1A expression The C-terminal activation regions 1 and 2 are regions of LMP1 involved in the activation of NF-kB. We then examined the ability of LMP1 variants with mutated CTAR1 and/or CTAR2 regions to downregulate RASS-F1A expression. The wild-type (wt) and mutant LMP1 plasmids used in this study were kindly provided by Professor Lawrence Young, University of Birmingham, UK; which include the pSG5 vector, pSG5B95.8 LMP1, the pSG5-B95.8LMP1 AxAxA (mutated CTAR1), pSG5-B95.8LMP1 378STOP (deleted in CTAR2) and pSG5-B95.8LMP1 AxAxA/378STOP (mutated CTAR1 and deleted CTAR2). This set of mutants have been used previously in defining the intracellular signaling of LMP1 (Eliopoulos and Young, 2001; Li et al., 2004) . The experiments were performed in both HeLa and HaCaT cells. In both cell types, mutation in CTAR1 and deletion in CTAR2 greatly diminished the suppression effect on RASSF1A downregulation ( Figure 2C ). In HeLa cells, LMP1 mutants deficient in CTAR1 or CTAR2 region still retained their abilities to downregulate RASSF1A ( Figure 2C , left panel). In HaCaT cells, CTAR1 mutant (pSG5-B95.8LMP1 AxAxA) retained its ability to suppress RASSF1A expression. However, the CTAR2 mutant (pSG5-B95.8LMP1 378STOP) could not completely retain its ability to suppress RASSF1A expression ( Figure 2C , right panel); which may be attributed to the stronger ability of CTAR2 to activate NF-kB signaling (Eliopoulos et al., 1999b) . The difference in response to CTAR1 and CTAR2 in different cell types is not fully understood, but may be related to the difference in endogenous RASSF1A level in different cell types. The HaCaT cell line has a higher endogenous level of RASSF1A expression compared to HeLa cells (Figures 1b and  2c ). These results conform to our previous observations that LMP1 suppression of RASSF1A expression involve LMP1 suppresses RASSF1A expression C Man et al NF-kB activation, and is mediated through the CTAR regions.
LMP1 suppresses RASSF1A promoter activity through NF-kB activation The effect of LMP1 expression on the transcription of RASSF1A was then examined using a promoter region of RASSF1A cloned 3.1 kb upstream from the ATG site of RASSF1A. Various deletion mutants of this 3.1 kb RASSF1A promoter region (À3101/À1, À1190/À1, À431/À1, À431/ þ 15, À300/À1, À202/À1) were subcloned into the pGL3-basic vector, upstream of the luciferase coding sequence. These promoter constructs were then examined for their usage in HK1 cells, a welldifferentiated squamous NPC (Huang et al., 1980) , which expressed high level of RASSF1A (Chow et al., 2006) . The transfection efficiency of the luciferase reporter of RASSF1A promoter was normalized by cotransfecting the cells with the pRL-SV40 as internal control. The two deleted RASSF1A promoter-reporter constructs (À431/À1 and À431/ þ 15) were shown to have the highest promoter usage in HK1 cells (Figure 3a ), and were selected for co-transfection studies with the wt LMP1 plasmid and LMP1 mutants. Human embrogenic kidney (HEK)293 cells were used in this part of study, as RASSF1A expression is high in this cell line. In agreement with the immunoblot study, wt B95.8 LMP1 effectively suppressed RASSF1A promoter usage. The suppression of RASSF1A promoter usage by this prototype (B95.8 LMP1) and the prevalent variant (2117-LMP1) could be restored by co-transfection with the NF-kB super suppressor (pUSE-IkBaS32/ S36) (Figure 3b and c). The ability to suppress RASSF1A promoter usage was lost in the LMP1 mutant (B95.8-LMP1 AxAxA/378STOP mutant), deficient in both CTAR regions. In comparison, the CTAR2 mutant (B95.8-LMP1 378STOP) is less effective compared to the CTAR1 mutant (B95-8-LMP1 AxAxA) in suppressing RASSF1A transcription; which may be attributed to the stronger ability of CTAR2 to activate NF-kB signaling (Eliopoulos et al., 1999b) . The promoter experiments confirm CTAR2 as the region responsible for RASSF1A suppression. There is, however, discrepancy between the immunoblot studies ( Figure 2c ) and the promoter analysis in defining the exact region involved (Figure 3b and c). One explanation is that HEK293 cells may have a higher endogenous transcription rate of RASSF1A compared to HeLa cells; however, the exact mechanism for the discrepancy remains to be elucidated.
LMP1 induces abnormal interphase microtubules and mitotic spindles
Loss of RASSF1A function has been previously reported to induce microtubule defects, mitotic checkpoint deregulation and chromosome instability (Song et al., 2004; Vos et al., 2004) . We then examined if downregulation of RASSF1A expression by LMP1 may result in similar phenotypes. First of all, we examined the effect of LMP1 on microtubule phenotypes by transfecting both the parental cell line (NP69) and the stable transfectant (NP69LMP1) with pEGFP-atubulin; and observed for alterations of microtubule morphology using live cell imaging microscopy. In the parental NP69 cells, typical microtubule networks were observed (Figure 4a ). Defective microtubule polymerization was observed in NP69LMP1 cells, which revealed as punctuated structures in the cytoplasm. To ensure that these abnormal phenotypes observed were not artifacts of transfection or cytotoxic effects due to overexpression of proteins, the cells were examined under phase contrast microscopy for the presence of intact membrane structure (Figure 4a , top row). They were subsequently fixed and immunostained with DM1a-anti-a-tubulin antibody to confirm that the distorted structures observed in live cell microscopy were truly microtubule in origin. Two hundred cells from the parental NP69 cell line and the NP69LMP1 stable cell line were quantitated for defective microtubules. Seventy five percent of the cells were shown to be defective in microtubule polymerization compared with 8% in the parental cells (Figure 4a ). Effect of LMP1 expression on microtubule perturbation was also investigated in other epithelial cell types (HaCaT, SCC12F and HeLa). For tracking LMP1-transfected cells, the DsRed expression plasmid was used as a transfection marker. Cells were co-transfected with LMP1 and DsRed expression plasmids at a 3:1 ratio. Interphase microtubules and mitotic spindles were examined only in DsRed-positive cells. Distorted microtubules and multipolar spindles were detected in LMP1-transfected cells (Figure 4b , bottom row); whereas normal interphase microtubules and bipolar spindles were detected in most of the control cells transfected with the empty vector (Figure 4b ). Two hundred interphase cells and 50 mitotic cells in random microscopic fields were quantitated for abnormal microtubules and spindles in each cell line. Around 30% of the LMP1-transfected cells revealed abnormal microtubule organization while 50-60% of LMP1-transfected cells revealed abnormal mitotic spindles (Figure 4b ). The higher percentage of multipolar spindles observed compared to the lower percentage of defective interphase microtubules observed in LMP1-transfected cells, suggest that spindle abnormalities may be induced by other effects of LMP1 beside microtubule perturbation.
In order to confirm that downregulation of RASSF1A expression by LMP1 contributed to the abnormal microtubule phenotype in LMP1 transfected cells, we performed co-transfection studies in HeLa cells using LMP1 and RASSF1A expression vectors. Expression of RASSF1A effectively rescued the abnormal microtubule phenotypes induced by LMP1 (Figure 4c ). We further confirmed that NF-kB is involved in contributing to the abnormal microtubule organization in the LMP1-expressing cells; by co-transfecting the NF-kB inhibitor (pUSE-IkBa S32/S36) and the LMP1 expression plasmid into SCC12F, HaCaT and HeLa cells. The empty vector, pSG5, was added where appropriate, to equalize the amount of DNA across all transfections. We LMP1 suppresses RASSF1A expression C Man et al observed a six to tenfold increase in microtubule defects in all three cell types transiently transfected with LMP1; whereas most control cells revealed normal interphase microtubule structures and bipolar mitotic spindles (Figure 4d) . Consistent with the promoter-reporter luciferase study, blocking NF-kB activation could effectively protect the cells from perturbed microtubule organization in LMP1-expressing cells (Figure 4d ).
LMP1 inhibits microtubule dynamics in cells
The distortion of interphase microtubules and increased in multipolar spindles in LMP1 expressing cells, suggested that LMP1 may interfere with microtubule dynamics. Retinal pigment epithelial (RPE) cells, which are commonly used in the study of microtubule dynamics was used in this part of study. The RPE cells used were stably transfected with pEGFP-EB1 expression plasmid (Rosa et al., 2006) . Microtubules' plus ends are binding sites for EB1 protein. EB1 is a microtubuledynamic regulating protein binding to the tip of growing microtubules (Karsenti and Vernos, 2001 ). The pattern of EGFP-EB1 expression could accurately reflect the dynamics of the polymerizing microtubules. Images of the EB1-transfected RPE cells were acquired by Figure 3 LMP1-dependent suppression of RASSF1A promoter activity involves NF-kB. (a) Deletion mutants of the 3.1 kb RASSF1A promoter region (À3101/À1, À1190/À1, À431/À1, À431/ þ 15, À300/À1, À202/À1) were co-transfected with pRL-SV40 (internal control) into HK1 cells. Dual luciferase assays were performed 48 h after transfection. Promoter usages of the RASSF1A reporter constructs were measured as ratios of the firefly luciferase activities to the control renilla activities. Empty vector was added to normalize the amount of vectors across all transfections. Relative promoter activities were normalized by the luciferase activity of the vector control (pGL-basic). (b) The RASSF1A promoter construct À431/À1 was co-transfected in HEK293 cells, with the prototype and the set of mutants or the HK prevalent variant; in the presence or absence of the NF-kB inhibitor (pUSE-IkBa S32/S36). Promoter activities were measured as (a). Ratios of the promoter activities between LMP1 expressing cells and the vector control of less than one represent suppression of RASSF1A promoter activity. (c) Same study performed using the RASSF1A promoter construct -431/ þ 15. (a) Analysis of microtubule structures in NP69 and its stable transfectant NP69LMP1 was performed by transient transfection using EGFP-a-tubulin. Live cells with abnormal microtubule morphology were quantified and imaged by stacked optical sections using confocal microscopy (n ¼ 200). Cells were subsequently checked under phase contrast for intact membranes. Difference described is statistically significant (t-test; Po0.0001, indicated by asterisk). (b) HaCaT, SCC12F and HeLa cells were co-transfected with 2117-LMP1 and a transfection marker (pDs-Red) at a 3:1 ratio. Empty vector (pcDNA3.1) was added to normalize the amount of vectors across all transfections. Interphase microtubules (n ¼ 200) and mitotic spindles (n ¼ 50) were analysed and quantified, after immunofluorescent staining with DM1a-anti-atubulin. Images were acquired by stacked optical sections using confocal microscopy. Interphase cells which lacked network-like organization were considered aberrant; and mitotic cells with monopolar or multipolar spindles were considered as abnormal. Representative images shown are sets of data from HaCaT cells. Differences described between control and LMP1 expressing cells are statistically significant (t-test; Po0.0005, indicated by single asterisk; Po0.0001, indicated by double asterisks). (c) The role of RASSF1A in LMP1-induced microtubule abnormalities was studied by co-transfecting B95.8-LMP1, the RASSF1A expression plasmids and the transfection marker (DsRed) into HeLa cells. Subsequent immunofluorescent analysis, image acquisition and quantification of microtubule defects, were performed as in (b). The difference described between cells expressing LMP1 alone and coexpressing LMP1 and RASSF1A, is statistically significant (t-test; Po0.0001, indicated by asterisk). (d) The involvement of NF-kB in the induction of microtubule defects was revealed by co-transfection of LMP1, pEGFP-a-tubulin and the genetic inhibitor of NF-kB (pUSE-IkBa S32/S36) in all transient systems previously used. Empty vector (pcDNA3.1) was added to normalize the amount of vectors across all transfections. Microtubule and spindle defects in LMP1-expressing cells were analysed, quantified and imaged as in (b, c). The set of data shown were representative images from the SCC12F cell line. Difference described is statistically significant (t-test; Po0.0005, indicated by single asterisk; Po0.001, indicated by double asterisks). Bars represent 8 mm for all panels.
LMP1 suppresses RASSF1A expression C Man et al confocal laser scanning microscope at 3 s intervals (Supplementary movies S1-S5). EB1-expressing RPE cells transfected with the empty vector (pSG5) revealed sharp and abundant EGFP foci distributed along the polymerizing microtubules (Figure 5a , Supplementary S1). When EB1-expressing RPE cells were transfected with the wt B95.8 LMP1 plasmid, a high percentage (40%) of cells has complete suppression of microtubule dynamics revealed in loss of EGFP-EB1 movements. EB1 movements were abolished as the EGFP tagged EB1 failed to bind to polymerizing microtubules in the LMP1-transfected cells. In some LMP1-transfected cells, the EGFP-EB1 appeared to loop around the nucleus, indicating aggregation of microtubule structures (Figure 5a, Supplementary S2-S4 ). RPE cells expressing the LMP1 mutants defective at either CTAR1 or CTAR2 region induced similar abnormal phenotype; although less number of cells revealed complete suppression of microtubule dynamic when the LMP1-expressing cells are defective at CTAR2; which may due to its potent activation of NF-kB (Eliopoulos et al., 1999b) . LMP1 mutant defective in both C-terminal activating regions, had minimal effect on microtubule dynamics (Figure 5a , Supplementary S5).
LMP1 overexpression induces chromosomal aberrations in RPE cells
Microtubule defects commonly lead to loss of cell polarity and spindle abnormalities (Doxsey, 2001) , resulting in mitotic chaos during chromosome segregation. We examined if chromosome abnormalities could be observed in LMP1 expressing cells. We have previously reported that stable expression of LMP1 could induce aneuploidy and structural chromosome rearrangements in an SV40T immortalized nasopharyngeal Figure 5 LMP1 inhibits microtubule dynamics and induces chromosomal aberrations in RPE cells. (a) Immortalized RPE hTert cells stably expressing EGFP-EB1 were co-transfected with wt LMP1 or the LMP1 mutants or the empty vector pSG5 with the transfection marker (Ds-Red) to examine the effect of LMP1 on microtubule dynamics. Cells which revealed sharp, abundant EGFP-EB1 foci distributed along the polymerizing microtubules were quantified as normal. Cells with no EGFP-EB1 tracks of movements were quantified as abnormal. Bars represent 8 mm for all panels. (b) Cytogenetics analyses were performed on the RPE hTert cells and the RPE hTert cells transfected with the B95.8-LMP1 wt expression plasmid and harvested after 48 h without any drug selection. Thirty cells from each cell line were analysed and karyotyped according to ISCN (1995) . RPE hTert cells reveal a cytogenetic profile of 44,X,t(2;X)(p13;q21),À3[20]/45,X,t(2;X)(p13;q21) [10] [cp30]. RPE hTert cells transfected with LMP1 reveal a cytogenetic profile of 45,X,t(2;X)(p13;q21)[22]/64,X,der(X)del(q23), þ der(X)del(q21)x2,der(1)add(1)(p11), þ der(1)del(1q24), þ 2, þ der(2),t(2;X)(p13;q21), del(4)(p12), þ 5, þ 6, þ der(6)del(q15), þ der(7)add(q35)x2, þ 8, þ 8,add(9)(p23), þ der (10)
. Arrows represent translocations between chromosomes 2 and X. The difference described is statistically significant (t-test; Po0.005).
LMP1 suppresses RASSF1A expression C Man et al epithelial cells . We have chosen the telomerase-immortalized retinal pigment epithelial cells (RPE hTert) because of their relatively normal and diploid karyotype, compared to cancer cells and other viral-protein immortalized cell types (Boukamp et al., 1997; Duensing and Munger, 2002) . RPE hTert only harbors one balanced translocation between chromosomes 2 and X (Figure 5b, i) . RPE hTert cells were transiently transfected with LMP1 and harvested for cytogenetic analyses. Transient expression of LMP1 effectively induced chromosomal abnormalities in RPE hTert cells (Figure 5b, ii) ; in which 30% of these cells revealed a hypotriploid karyotype. Detail cytogenetic alterations are described in the legend of Figure 5 . This is the first demonstration that transient LMP1 expression could induce chromosomal instability in human epithelial cells.
Discussion
EBV infection is an early event in the development of NPC and has been postulated to be involved in the malignant transformation of premalignant nasopharyngeal epithelium into cancer. The EBV encoded LMP1 is believed to have oncogenic properties and were detected in premalignant lesions of nasopharyngeal epithelium (Pathmanathan et al., 1995) . In this study, a novel function of LMP1 in downregulation of RASSF1A expression was identified; which supports its role in early pathogenesis of NPC. Recent studies have shown that RASSF1A plays important roles in regulating events in mitosis and has marked influence on microtubules' behavior as well as on chromosome instability (Mathe, 2004) . RASSF1A is a microtubule-associated protein and could be localized to the spindle poles in mitotic cells, where its expression would regulate mitosis (Vos et al., 2004) . Cells depleted in RASSF1A exit mitosis prematurely with severe chromosome segregation defects (Song et al., 2004) .
The tumor-suppressor function of RASSF1A in NPC has been demonstrated in a RASSF1A-deficient NPC cell line (C666-1). As mentioned in the introduction section, RASSF1A could be inactivated by methylation or deletion in human cancers. Although RASSF1A is viewed as being indispensable for cell division, given the catastrophic mitotic defects induced by abrogation of this protein, there has not been any study of how a viral oncogene could regulate this protein. In this study, we showed that LMP1 could modulate the organization and/or function of microtubules; hence, this viral oncoprotein may induce multipolar spindles and chromosome instability. These are unreported phenotypes of LMP1. Nonetheless, these phenotypes are associated with those in RASSF1A inactivated cells. We further demonstrated that the effects of LMP1 on microtubules are via RASSF1A, by rescuing the phenotype in cells co-transfected with both LMP1 and RASSF1A. In this study, we have elaborated some of the mechanisms involved in the downregulation of RASSF1A by LMP1. The two functional domains (CTAR1 and CTAR2) of this viral oncogene are known to be involved in NF-kB activation (Eliopoulos et al., 1999b) . The LMP1 mutant, deficient in both CTAR domains, was incapable of downregulating RASSF1A expression; suggesting that NF-kB activation may mediate LMP1-induced downregulation of RASSF1A. Based on the RASSF1A promoter analyses and the microtubule dynamic studies, we further confirmed the importance of the LMP1 CTAR2 region in suppression of RASSF1A.
We previously revealed that overexpression of survivin could dramatically reduce microtubule nucleation and dynamics (Rosa et al., 2006) . Interestingly, survivin is also a downstream target of LMP1 expression and NFkB activation. The implication of LMP1 expression in chromosome instability was revealed in another study, showing that expression of LMP1 increases the sensitivity of epithelial cells to DNA damage resulting in micronuclei formation (Liu et al., 2004) .
The demonstration that a viral oncogene could downregulate a tumor-suppressor gene is of direct relevance to the role of tumorigenic virus in the pathogenesis of human cancers. The inactivation of tumor-suppressor gene by tumorigenic virus is welldocumented in human papilloma virus. The expression of the E6 and E7 oncogenes could inactivate the p53 and Rb genes, respectively. It was indicated that the E6/E7 oncogene could activate aurora A and induce polyploidy (Patel et al., 2004) . In NPC, a close association with EBV infection is present. EBV infection is an early and clonal event in NPC (Pathmanathan et al., 1995) . LMP1 could be detected at high level in premalignant lesion of nasopharyngeal epithelium and low-grade NPC (Pathmanathan et al., 1995) . The findings that LMP1 could downregulate RASSF1A expression and induce chromosome instability support a role of EBV encoded oncogene in the pathogenesis of NPC.
Materials and methods
Cell lines NP69 (Tsao et al., 2002b) and NP69LMP1 (Lo et al., 2003) cells are immortalized nasopharyngeal epithelial cell lines, previously established in our laboratory. HK1 is a cancer cell line established from a well-differentiated NPC (Huang et al., 1980) , and was used in our previous RASSF1A studies (Chow et al., 2004 (Chow et al., , 2006 . HeLa and HEK293 cells were from ATCC (Manassas, VA, USA). Both cell types were maintained in Rosewell's Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum (FBS). HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. HaCaT and SCCF12 cells were kindly provided by Dr Dawson, University of Birmingham, UK. They were maintained in DMEM and DMEM: HAMF12 medium in a 3:1 ratio, respectively. The RPE hTert were obtained from Clontech (CA, USA); and has been used in previous studies of microtubule function (Rosa et al., 2006) .
Transient transfections and plasmids
Transient transfections were achieved using Fugene 6 transfection reagent (Roche Molecular Biochemicals Inc., IN, USA) according to the manufacturer's recommendations. Sources and references of the expression plasmids used are: prevalent LMP1 suppresses RASSF1A expression C Man et al LMP1 variant of NPC (2117-LMP1) isolated from an NPC xenograft (Cheung et al., 1998) ; prototype LMP1 (B95.8-LMP1) was cloned from the B95.8 cell line. The prevalent variant was cloned into the pcDNA3.1 expression vector (Invitrogen, CA, USA). The wt and mutants prototype LMP1 (pSG5 B95.8-LMP1 wt, pSG5 B95.8-LMP1 AxAxA, pSG5 B95.8-LMP1 378STOP and pSG5 B95.8-LMP1 AxAxA/ 378STOP) were provided by Professor Lawrence Young, University of Birmingham, UK. The cloning and biological properties of the wt and mutant LMP1 have been previously described (Eliopoulos et al., 1999a) . Genetic suppressor of NF-kB (pUSE-IkBa S32/S36) and the activator of NF-kB (pRc-bactin-IKKa) had been described previously (Jin et al., 1999) . The plasmid for imaging microtubule structure (pEGFP-a-tubulin) and the plasmid for imaging dynamics of microtubule plus-ends binding protein in live cells (pEGFP-EB1) had been described (Rosa et al., 2006) . Transfection marker (pDsRed) was obtained from Clonetech laboratories Inc., CA, USA.
Transient reporter assays
The effect of LMP1 expression on the transcription of RASSF1A was examined using a 3.1 kb promoter region of RASSF1A upstream from the ATG site of the reported RASSF1A cDNA sequence. Various deletion fragments of the 3 kb RASSF1A promoter region (À3101/À1, À1190/À1, À431/ À1, À431/ þ 15, À300/À1, À202/À1) were subcloned into the pGL3-basic vector, upstream of the luciferase coding sequence and examined for the promoter usage in transfected cells. The suppressing effect of LMP1 on RASSF1A promoter activity was assayed as previously described (Li et al., 2004) . For a typical transfection, 0.25 mg of RASSF1A reporter, 0.01 mg of control reporter (pRL-SV40) and 0.1 mg of LMP1 expression plasmid were co-transfected with Fugene 6 transfection reagents (Roche Molecular Biochemicals Inc., USA). Readings were taken using the Dual-Luciferase Reporter Kit (Promega, WI, USA). All experiments were conducted in triplicates using independent cultures.
Immunofluorescence analysis Cells were fixed in À201C methanol, blocked with 1% bovine serum albumin, permeabilized with 0.5% Triton X-100 and stained with antibody against a-tubulin using DM1a-anti-atubulin (Doxsey et al., 1994) ; followed by Rhodamineconjugated anti-mouse antibody (Dako, Glostrup, Denmark). Microtubule morphology was captured by acquiring stacked optical sections using multiphoton confocal microscopy (Zeiss LSM 510, NY, USA), with Â 63 objective from eight random fields. Two hundred interphase cells and 50 mitoses were scored for microtubule defects and abnormal mitotic spindles.
Live microscopy of GFP-EB1 RPE hTert cells stably expressing EGFP-EB1 were seeded onto glass bottom microwell dishes (MatTek Corporation, Ashland, MA, USA) EGFP-EB1. Images at defined zoom ( Â 63 objective, Â 1.5 zoom) and depth (0.2 mm) were acquired every 3 s for 3 min using a confocal laser scanning microscope (Zeiss LSM 510) and compacted into time-lapse movies. Where indicated, cells were co-transfected with various LMP1 expression plasmids and mutants.
Karyotypic analysis
Cytogenetic analyses were performed as described previously (Li et al., 2006) . Briefly, colcemid solution (10 mg/ml) (Invitrogen, CA, USA) was added for 10-16 h, exposed to hypotonic solution (0.06 M KCl) and fixed in methanol plus acetic acid (3:1 ratio) for three times. Metaphase spreads were treated by 0.025% trypsin and subsequently stained (Giemsa Gurr R66, Biomedical specialties, CA, USA). Thirty cells from each cell line were karyotyped according to the International System for Human Cytogenetic Nomenclature (ISCN, 1995) using the Cytovision software (Applied imaging, Hampshire, UK).
RT-PCR
Detection of RASSF1A transcripts were performed by semiquantitative RT-PCR analysis as previously described (Chow et al., 2004) . Primers used were, forward: 5 0 -CAGATTGCAAGTTCACCTGCCACTA-3 0 , reverse: 5 0 -GATGAAGCCTGTGTAAGAACCGTCCT-3 0 ; which flank exon 2ab and exon 4 of the gene; and the annealing temperature was at 651C (28 cycles). Relative levels of b-actin expression were normalized as loading control.
Western blotting analysis
Cells were harvested and protein concentrations were determined as previously described (Li et al., 2004) . Protein (30 mg) was resolved on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto a nitrocellulose membrane (Immobilon-P; Millipore, Bedford, MA, USA). Primary antibodies used were anti-RASSF1A (1:500, eBioscience, CA, USA), anti-LMP1 (1:2000, CS1-4, Dakocytomation, Glostrup, Denmark), anti-NF-kB (p65, 1:1000, Santa Cruz Biotechnology, CA, USA), anti-p-IkBa (1:500, Santa Cruz Biotechnology, CA, USA), antihistone (1:1000, Santa Cruz Biotechnology, CA, USA), antiactin (1:1000, Santa Cruz Biotechnology, CA, USA). Chemical inhibitors used were: JNK inhibitor II for the JNK pathway and U0126 for the ERK1/2 pathway and LY294002 for the Akt pathway. Concentrations and durations of treatments were previously optimized (Li et al., 2004) . Actin was used as loading control. Relative protein expression levels were quantified by gel documentation system (Ultra-Violet Product Ltd, CA, USA).
Statistical method
Student's t-test was used where applicable. The mean percentage and standard error of three independent experiments and at least 200 interphase cells or 50 mitotic cells evaluated per experiment are given.
